Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix

American Journal of Clinical Pathology

Volumn 130, Issue 3, 2008, Pages 389-400

  Ueda, Yutaka ^a   Miyatake, Takashi ^a   Okazawa, Mika ^a   Kimura, Toshihiro ^a   Miyake, Takahito ^a   Fujiwara, Kazuko ^a   Yoshino, Kiyoshi ^a   Nakashima, Ryuichi ^a   Fujita, Masami ^a   Enomoto, Takayuki ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosquamous; Clonality; Concurrent; Episomal; Glandular; HPV; Integrated; Squamous; Uterine cervix

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CLONAL VARIATION; DISEASE COURSE; DYSPLASIA; EPISOME; FEMALE; HISTOGENESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS; X CHROMOSOME INACTIVATION;

ADENOCARCINOMA; ANTIBODIES, VIRAL; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 51349137120     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/ERR93AF840YYNDRQ     Document Type: Article

References (53)

1. Iwasaka T, Yokoyama M, Matsuo N. In situ hybridization analysis of human papillomavirus DNA in cervical intraepithelial neoplasia. Cervix Lower Female Genital Tracts. 1994;12:55-59.
2. Noda K, Yajima A, Higashiiwai H, et al. Histopathologic criterion of dysplasia of the uterine cervix and its biological nature. Acta Cytol. 1976;20:224-228.
3. Anciaux D, Lawrence WD, Gregoire L. Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status. Int J Gynecol Pathol. 1997;16:103-110.
4. Kurman RJ, Norris H, Wilkinson E. Tumors of Cervix, Vagina, and Vulva. Washington, DC: Armed Forces Institute of Pathology; 1992:77-100.
5. Atlas of Tumor Pathology; Third series, Fascicle 4.
6. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:275-277. World Health Organization Classification of Tumours.
7. van Aspert-van Erp AJM, Smedts FMM, Vooijs GP. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the Papanicolaou smear. Cancer. 2004;102:210-217.
8. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus type and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study in situ DNA hybridization. Cancer Res. 1988;48:993-998.
9. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial lesions. Int J Gynecol Pathol. 1989;8:8-17.
10. Riethdorf S, Riethdorf L, Milde-Langosch K, et al. Differences in HPV 16 and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinoma of the cervix uteri. Virchows Arch. 2004;437:491-500.
11. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, NY: Springer-Verlag; 1994:279-326.
12. An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol. 2005;18:528-534.
13. Yamakawa Y, Forslund O, Teshima H, et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol. 1994;53:190-195.
14. Das BC, Sharma JK, Gopalakrishna V, et al. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol. 1992;73:2327-2336.
15. Stoler MH, Rhodes CR, Whitbeck A, et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol. 1992;23:117-128.
16. Nagao S, Yoshinouchi M, Miyagi Y, et al. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol. 2002;40:863-867.
17. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002;40:886-891.
18. Ueda Y, Enomoto T, Miyatake T, et al. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest. 2003;83:1517-1527.
19. Kersemaekers AMF, van de Vijver MJ, Fleuren GJ. Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix: a report of two cases. Int J Gynecol Pathol. 2000;19:225-230.
20. Fialkow PJ. Clonal origin of human tumors. Biochem Biophys Acta. 1976;485:283-321.
21. Enomoto T, Fujita M, Inoue M, et al. Analysis of clonality by amplification of short tandem repeats: carcinomas of the female reproductive tract. Diagn Mol Pathol. 1994;3:292-297.
22. Mandel JL, Manaco AP, Nelson DL, et al. Genome analysis and the human X chromosome. Science. 1992;258:103-109.
23. Riggs AD, Pfeifer GP. X-chromosome inactivation and cell memory. Trends Genet. 1992;8:169-174.
24. Wada H, Enomoto T, Fujita M, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res. 1997;57:5379-5385.
25. Wada H, Enomoto T, Yoshino K, et al. Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasia. Am J Clin Pathol. 2000;114:371-379.
26. Allen RC, Zoghbi HY, Moseley AB, et al. Methylation of HpaI and HhaII sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229-1239.
27. Sun H, Enomoto T, Shroyer KR, et al. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia. Diagn Mol Pathol. 2002;11:204-211.
28. Fujinaga Y, Shimada M, Okazawa K, et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 1991;72:1039-1044.
29. Kalantari M, Karlsen F, Kristensen G, et al. Disruption of the E1 and E2 reading frames of HPV16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol. 1998;17:146-153.
30. Corden SA, Sant-Cassia LJ, Easton AJ, et al. The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol. 1999;52:275-282.
31. Park JS, Hwang ES, Park SN, et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol. 1997;65:121-129.
32. Yutsudo M, Okamoto Y, Hakura A. Functional dissociation of transforming genes of human papillomavirus type 16. Virology. 1988;166:594-597.
33. Nakanishi K, Yong-Il H, Ishiwatari H, et al. Isolation of flat revertants from human papillomavirus type 18 E6E7 transformed 3Y1 cells by transfection with a rat embryo fibroblast cDNA expression library. Cell Struct Funct. 1993;18:457-465.
34. Ueda Y, Enomoto T, Miyatake T, et al. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa. Am J Clin Pathol. 2004;122:266-274.
35. Huang FY, Kwok YK, Lau ET, et al. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet. 2005;157:42-48.
36. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991;184:9-13.
37. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64:3878-3884.
38. Nuovo GJ, Plaia TW, Belinsky SA, et al. In situ detection of hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A. 1999;96:12754-12759.
39. Virmani AK, Muller C, Rathi A, et al. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 2001;7:584-589.
40. Dong SM, Kim HS, Rha SH, et al. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res. 2001;7:1982-1986.
41. Yoshino K, Enomoto T, Nakamura T, et al. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer. 1998;76:176-181.
42. Hadzisejdć I, Krasević M, Haller H, et al. Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma. Coll Antropol. 2007;31(suppl 2):97-102.
43. Sano T, Shimooka H, Weixa P, et al. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int. 2004;54:743-750.
44. Kuzmin I, Liu L, Dammann R, et al. Inactivation of RAS association family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res. 2003;63:1888-1893.
45. Niho S, Yokose T, Kodama T, et al. Clonal analysis of adenosquamous carcinoma of the lung. Jpn J Cancer Res. 1999;90:1244-1247.
46. Kanazawa H, Ebina M, Ino-Oka N, et al. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol. 2000;156:1289-1298.
47. van Rees BP, Rouse RW, de Wit MJ, et al. Molecular evidence for the same clonal origin of both components of an adenosquamous Barrett's carcinoma. Gastroenterology. 2002;122:784-788.
48. Wilbur DC, Bonfiglio TA, Stoler MH. Continuity of human papillomavirus (HPV) type between neoplastic precursors and invasive cervical carcinoma: an in situ hybridization study. Am J Surg Pathol. 1988;12:182-186.
49. Zaino RJ. Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 2002;21:314-326.
50. Jordan CT, Guzman ML, Nobel M. Cancer stem cells. N Engl J Med. 2006;355:1253-1261.
51. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev. 2005;5:275-284.
52. Spillane J, Henderson MA. Cancer stem cells: a review. ANZ J Surg. 2007;77:464-468.
53. Park JJ, Sun D, Quade BJ, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol. 2000;24:1414-1419.